Publications
Events
Advertise
Subscribe
MyBN
Log In
Search
Menu
Close Navigation
Login
MyBN
Latest News
Resources
Property
Commercial Content
Back to previous menu
Close
Commercial Content
Announcements
Bulls N' Bears
Business Advice
Hearts & Minds
Industry Content
Skyline
Thought Leadership
All Categories
Back to previous menu
Close
All Categories
Resources
Property
Deals
Opinion
Government
Agribusiness
Education
Health
Infrastructure
Oil & Gas
Remuneration
Retail
Small Business
Technology, Innovation & Science
Tourism
Transport & Logistics
Explore All Categories
Data & Insights
Publications
Events
Advertise
Subscribe
Lists
Graham Melrose
Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN
Log In
Graham Melrose
Graham Melrose is the founder of biotech company Recce and inventor of RECCE antibiotics. Dr Melrose is best known as the founder of now defunct biotech company Chemeq.
Lists and Charts
Total Shareholder Return
as at 31/10/24
Rank
Company
1 yr
5 yr
785
th
Recce Pharmaceuticals
4%
12%
View Full List
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
16/01/17
$0 Bought
Recce Pharmaceuticals
16/01/17
$0 Other
Recce Pharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
Rank
Company
Revenue
th
Recce Pharmaceuticals
$5.0m
View Full List
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
News Articles
Related Information
Positions
- Previous
Position
Company
Year
Company's current rank
Executive Chairman
Recce Pharmaceuticals
2007 -
Directors Interests
Company
Date
Transaction type
Number of shares
Price per share
Transaction value
Nature of change
Recce Pharmaceuticals
16 Jan 2017
Bought
1,059,000
Other
Conversion of securities
Recce Pharmaceuticals
16 Jan 2017
Other
1,059,000
Other
Conversion of securities: 18225000 - Performance Shares.
View All
Powered by Morningstar ®
Subscribe today for award-winning, unbiased and trusted journalism
Subscription Options